Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
Lambrou AS, Shirk P, Steele MK, Paul P, Paden CR, Cadwell B, Reese HE, Aoki Y, Hassell N, Zheng XY, Talarico S, Chen JC, Oberste MS, Batra D, McMullan LK, Halpin AL, Galloway SE, MacCannell DR, Kondor R, Barnes J, MacNeil A, Silk BJ, Dugan VG, Scobie HM, Wentworth DE, Caravas J, Kovacs NA, Gerhart JG, Jia Ng H, Beck A, Chau R, Cintron R, Cook PW, Gulvik CA, Howard D, Jang Y, Knipe K, Lacek KA, Moser KA, Paskey AC, Rambo-Martin BL, Nagilla RR, Retchless AC, Schmerer MW, Seby S, Shepard SS, Stanton RA, Stark TJ, Uehara A, Unoarumhi Y, Bentz ML, Burgin A, Burroughs M, Davis ML, Keller MW, Keong LM, Le SS, Lee JS, Madden Jr JC, Nobles S, Owuor DC, Padilla J, Sheth M, Wilson MM; Strain Surveillance and Emerging Variants Bioinformatic Working Group; Strain Surveillance and Emerging Variants NS3 Working Group. Lambrou AS, et al. Among authors: le ss. MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):206-211. doi: 10.15585/mmwr.mm7106a4. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35143464 Free PMC article.
Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.
Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Dunnigan K, Foust A, Sessions W, DaSilva J, Le S, Stark T, Kondor RJ, Barnes JR, Wentworth DE, Brammer L, Fry AM, Patel MM, Flannery B. Dawood FS, et al. Among authors: le s. MMWR Morb Mortal Wkly Rep. 2020 Feb 21;69(7):177-182. doi: 10.15585/mmwr.mm6907a1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32078591 Free PMC article.
Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.
Sun X, Belser JA, Pappas C, Pulit-Penaloza JA, Brock N, Zeng H, Creager HM, Le S, Wilson M, Lewis A, Stark TJ, Shieh WJ, Barnes J, Tumpey TM, Maines TR. Sun X, et al. J Virol. 2018 Dec 10;93(1):e01740-18. doi: 10.1128/JVI.01740-18. Print 2019 Jan 1. J Virol. 2018. PMID: 30305359 Free PMC article.
Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TM, Monto AS, Martin ET, Zimmerman RK, Silveira FP, Middleton DB, Olson SM, Garten Kondor RJ, Barnes JR, Ferdinands JM, Patel MM; Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) Investigators. Tenforde MW, et al. J Infect Dis. 2021 Sep 1;224(5):813-820. doi: 10.1093/infdis/jiaa800. J Infect Dis. 2021. PMID: 33378531 Free PMC article.
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
Olson SM, Newhams MM, Halasa NB, Feldstein LR, Novak T, Weiss SL, Coates BM, Schuster JE, Schwarz AJ, Maddux AB, Hall MW, Nofziger RA, Flori HR, Gertz SJ, Kong M, Sanders RC, Irby K, Hume JR, Cullimore ML, Shein SL, Thomas NJ, Stewart LS, Barnes JR, Patel MM, Randolph AG; Pediatric Intensive Care Influenza Investigators. Olson SM, et al. Clin Infect Dis. 2022 Aug 25;75(2):230-238. doi: 10.1093/cid/ciab931. Clin Infect Dis. 2022. PMID: 35024795
Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
Ferdinands JM, Gaglani M, Ghamande S, Martin ET, Middleton D, Monto AS, Silveira F, Talbot HK, Zimmerman R, Smith ER, Patel M; US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) Study Investigators. Ferdinands JM, et al. J Infect Dis. 2021 Jul 2;224(1):151-163. doi: 10.1093/infdis/jiaa772. J Infect Dis. 2021. PMID: 33336702 Free PMC article.
Rho family GTPase inhibition reveals opposing effects of mitogen-activated protein kinase kinase/extracellular signal-regulated kinase and Janus kinase/signal transducer and activator of transcription signaling cascades on neuronal survival.
Loucks FA, Le SS, Zimmermann AK, Ryan KR, Barth H, Aktories K, Linseman DA. Loucks FA, et al. Among authors: le ss. J Neurochem. 2006 May;97(4):957-67. doi: 10.1111/j.1471-4159.2006.03802.x. J Neurochem. 2006. PMID: 16686690 Free article.
18 results